Results 81 to 90 of about 50,638 (234)
The Journal of Dermatology, EarlyView.ABSTRACT Amenamevir is a novel anti‐herpes zoster drug that is increasingly used in Japan because of its once‐daily administration and lack of renal dose adjustment requirements. However, evidence of its clinical effectiveness is limited. This study aimed to estimate the clinical effectiveness of amenamevir vs. valacyclovir in preventing zoster‐related
Yasuhiro Kano +2 more
wiley +1 more source
Allergy, EarlyView.ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source
Infection control in the brain and the eye
Acta Ophthalmologica, EarlyView.Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester +2 more
wiley +1 more source
A case of tri-segmental cranial nerve V herpes zoster
IDCases, 2019 Varicella-zoster is the causative virus underlying varicella or “chickenpox” and herpes zoster or “shingles.” Cases of disseminated disease have been widely reported in immunocompromised patients.
Hena S. Cheema +3 more
doaj +1 more source
Acta Paediatrica, EarlyView.ABSTRACT Aim Countries with varicella immunisation programmes have seen major reductions in disease burden. While two‐dose schedules are now universally adopted, dosing ages vary, and some countries initially include catch‐up vaccination of older children to speed impact. This modelling study assessed three two‐dose schedules in the Swedish setting (1)
Gianpaolo Scalia Tomba +6 more
wiley +1 more source
Influence of meteorological conditions on herpes zoster occurrence: a retrospective cohort study
Frontiers in MedicineIntroductionHerpes zoster is caused by the reactivation of the varicella zoster virus, typically affecting older adults and immunocompromised individuals.
Michał Ochal +4 more
doaj +1 more source
Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme
Acta Paediatrica, EarlyView.ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson +2 more
wiley +1 more source
Acta Paediatrica, EarlyView.ABSTRACT Aim To assess the cost‐effectiveness of including varicella vaccination in the Swedish national vaccination programme for children together with the added impact of catch‐up vaccination of susceptible older children. Methods An epidemiological transmission model was used to assess the cost‐effectiveness of a two‐dose national varicella ...
Frida Kasteng +5 more
wiley +1 more source
British Journal of Haematology, EarlyView.In newly diagnosed multiple myeloma patients in ≥Very Good Partial Remission (VGPR) after a first‐line therapy daratumumab as consolidation/maintenance improved long‐term minimal residual disease negativity. Summary Daratumumab is approved for front‐line and relapsed myeloma therapy.
Alessandro Gozzetti +24 more
wiley +1 more source
PLoS ONE, 2014 BackgroundThe association between liver cirrhosis (LC) and herpes zoster has rarely been studied. We investigated the hypothesis that LC, known as an immunodeficiency disease, may increase the risk of herpes zoster using a national health insurance ...
Ping-Hsun Wu +4 more
doaj +1 more source